Key Financial Data Of Reporting Company

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7722876

Concept 2018-01-01 to
2018-06-30
As at
2018-06-30
2018-04-01 to
2018-06-30
2017-01-01 to
2017-12-31
As at
2017-12-31
As at
2017-06-30
2017-04-01 to
2017-06-30
2017-01-01 to
2017-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
72,678,000,000 JPY
156,761,000,000 JPY
67,307,000,000 JPY
Ordinary profit (loss)
11,533,000,000 JPY
24,191,000,000 JPY
10,244,000,000 JPY
Net assets
159,552,000,000 JPY
153,811,000,000 JPY
144,505,000,000 JPY
Total assets
217,101,000,000 JPY
218,831,000,000 JPY
199,625,000,000 JPY
Basic earnings (loss) per share
96.58
48.19
201.31
45.60
89.44
Diluted earnings per share
96.50
201.03
89.31
Equity-to-asset ratio
0.735 xbrli:pure
0.703 xbrli:pure
0.724 xbrli:pure
Net cash provided by (used in) operating activities
6,418,000,000 JPY
22,350,000,000 JPY
9,191,000,000 JPY
Net cash provided by (used in) investing activities
-7,618,000,000 JPY
7,039,000,000 JPY
4,813,000,000 JPY
Net cash provided by (used in) financing activities
-2,035,000,000 JPY
-9,162,000,000 JPY
-7,025,000,000 JPY
Cash and cash equivalents
45,054,000,000 JPY
48,688,000,000 JPY
35,069,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.